market access

Partner Content

$Banner for Media partners {460x250px}_4th Antibody Drug Conjugates$

Partner Content

4th Annual Antibody Drug Conjugates (ADC) Summit: From Targe...

We are pleased to invite you to the 4th Annual Antibody Drug Conjugates Summit: From Target to Therapeutics scheduled for May 15-16, 2019 in Vienna, Austria.

News

US drug cost body calls for SMA drug price cuts

A US drug cost-effectiveness group has said that Biogen should cut the price of its already-approved spinal muscular atrophy (SMA) drug, while the $4-$5 million Novartis is suggesting for a

News

NICE recommends interim funding for Lilly's breast cancer dr...

Final draft guidance from NICE has recommended interim NHS funding for Eli Lilly’s Verzenios (abemaciclib) with fulvestrant, giving certain breast cancer patients an option that can delay c

News

NICE backs funding for MSD's diabetes drug Steglatro

NICE has recommended that England’s NHS should routinely fund Merck, Sharpe, and Dohme’s type 2 diabetes drug Steglatro in a final decision, after the company undercut rivals from the same

News

Health secretary hints at 'constructive' talks over CF drugs

Health secretary Matt Hancock has offered hope to thousands of people in the UK who have been denied access to powerful cystic fibrosis drugs because of a row over pricing with manufacturer

News

Illustration of a nerve cell on a colored background with light effects

Acadia faces US federal probe into Nuplazid marketing

Acadia Pharmaceuticals may have thought it got out of trouble last year after an FDA safety investigation into its flagship Parkinson’s drug Nuplazid revealed no new risks – but documents h

4th Annual Antibody Drug Conjugates (ADC) Summit: From Targe...

US drug cost body calls for SMA drug price cuts

NICE recommends interim funding for Lilly's breast cancer dr...

NICE backs funding for MSD's diabetes drug Steglatro

Health secretary hints at 'constructive' talks over CF drugs

Acadia faces US federal probe into Nuplazid marketing

Dexcom is first to join FDA/CMS health tech pilot

Discover a new era of healthcare panel engagement: Grounded ...

market access

Editor's Picks